GBI Research Reports

GBI Research Reports

GBI Research covers worldwide markets and issues, supplies actionable data and forecasts and is driven by industry leaders' insights. GBI Research provides a broad spectrum of reports across the healthcare and energy industries and its online offering is easy to navigate - a comprehensive resource for business information needs.

Search GBI Research Reports
Latest Reports from GBI Research Reports
< Previous1617181920212223242526272829303132333435Next >
NameDate
Emerging Market for Clinical Trials in Argentina - Major Cost Advantages over the US in Conducting Clinical Trials Will Encourage Drug DevelopmentJul 01, 2011
...Emerging Market for Clinical Trials in Argentina - Major Cost Advantages over the US in Conducting Clinical Trials Will Encourage Drug Development GBIHC###MR /Published JUL #### Page # © GBI Research. This is a licensed product and is not to be photocopied...
Emerging Market for Clinical Trials in Russia - Curbs on New Drug Approval Timelines and Registration Fees Encourage the Emergence of a Major Global PlayerJul 01, 2011
...Emerging Market for Clinical Trials in Russia - Curbs on New Drug Approval Timelines and Registration Fees Encourage the Emergence of a Major Global Player GBIHC###MR / Published JUL #### Page # © GBI Research. This is a licensed product and is not...
Field Programmable Gate Array (FPGA) Market to 2020 - Increasing Preference for FPGAs over Application Specific Integrated Circuits (ASICs) will Drive DemandJul 01, 2011
...Field Programmable Gate Array (FPGA) Market to #### - Increasing Preference for FPGAs over Application Specific Integrated Circuits (ASICs) will Drive Demand GBISC####MR / Published JUL #### Page # © GBI Research. This is a licensed product and is not to be photocopied...
Emerging Market for Clinical Trials in Brazil - Improved Guidelines from ANVISA and CONEP are Shortening the Regulatory Approval Process and Advancing the MarketJul 01, 2011
...Emerging Market for Clinical Trials in Brazil - Improved Guidelines from ANVISA and CONEP are Shortening the Regulatory Approval Process and Advancing the Market GBIHC###MR / Published JUL #### Page # © GBI Research. This is a licensed product and is not to...
Paint Additives Market to 2016 - Rheology Modifiers and Biocides to Drive the MarketJul 01, 2011
...Paint Additives Market to #### - Rheology Modifiers and Biocides to Drive the Market GBICH####MR / Published JUL #### Page # © GBI Research. This is a licensed product and is not to be photocopied Paint Additives Market to #### - Rheology Modifiers and...
Private Equity and Venture Capital (PE/VC) Activity in Medical Devices - Number of Investments in Smaller Companies has Increased over the Past Four YearsJul 01, 2011
...Private Equity and Venture Capital (PE/VC) Activity in Medical Devices - Number of Investments in Smaller Companies has Increased over the Past Four Years GBIME####MR /Published JUL #### Page # © GBI Research. This is a licensed product and is not...
Kidney and Renal Diseases Therapeutics Market to 2017 - Strong Pipeline and Unmet Need Due to Poor Safety Profiles to Create Opportunities for GrowthJun 25, 2011
...Kidney and Renal Diseases Therapeutics Market to #### - Strong Pipeline and Unmet Need Due to Poor Safety Profiles to Create Opportunities for Growth GBIHC###MR /Published SEP #### Page # © GBI Research. This is a licensed product and is not to...
Orthobiologics Market to 2016 - Alternatives to Surgery and Superior Outcomes are Driving Wider Adoption of OrthobiologicsJun 25, 2011
...#Orthobiologics Market to #### - Alternatives to Surgery and Superior Outcomes are Driving Wider Adoption of Orthobiologics GBIME####MR /Published JUN #### Page # © GBI Research. This is a licensed product and is not to be photocopied Orthobiologics Market to #### - Alternatives...
Lead Generation Strategies and Technologies in Drug Development - Emerging Techniques Such as Antisense Technology Will Allow Innovators to Minimize CostsJun 10, 2011
...Lead Generation Strategies and Technologies in Drug Development - Emerging Techniques Such as Antisense Technology Will Allow Innovators to Minimize Costs GBIHC###MR / Published JUN #### Page # © GBI Research. This is a licensed product and is not to be photocopied Lead...
Impact of Counterfeits on Pharmaceutical Industry - Counterfeiting Poses Threats to Patient Safety and Revenues of Pharmaceutical CompaniesJun 10, 2011
...Impact of Counterfeits on Pharmaceutical Industry - Counterfeiting Poses Threats to Patient Safety and Revenues of Pharmaceutical Companies GBIHC###MR /Published JUN #### Page # © GBI Research. This is a licensed product and is not to be photocopied Impact of Counterfeits on...
Vinyls Market in the Americas to 2020 - Sustained PVC Demand to Boost RevenuesJun 10, 2011
...Vinyls Market in the Americas to #### - Sustained PVC Demand to Boost Revenues GBICH####MR /Published JUN #### Page # © GBI Research. This is a licensed product and is not to be photocopied Vinyls Market in the Americas to #### - Sustained...
Impact of US Healthcare Reforms - the Extension of Care to 32 Million Uninsured Citizens from 2014 and Implications for the Pharmaceutical IndustryJun 10, 2011
...Impact of US Healthcare Reforms ­ the Extension of Care to ## Million Uninsured Citizens from #### and Implications for the Pharmaceutical Industry GBIHC###MR /Published JUN #### Page # © GBI Research. This is a licensed product and is not to be...
Power Market in Western Europe to 2020 - Government Policies Downplaying the Nuclear Energy Industry and Spurring the Growth of Renewable EnergyJun 01, 2011
...Power Market in Western Europe to #### - Government Policies Downplaying the Nuclear Energy Industry and Spurring the Growth of Renewable Energy GBIPE####MR /Published JUN #### Page # © GBI Research. This is a licensed product and is not to be photocopied...
Opioids Market to 2017 - Steady Uptake of Oxycontin and High Incidence Of Diseases Such As Cancer And Arthritis to Drive the MarketJun 01, 2011
...Opioids Market to #### - Steady Uptake of Oxycontin and High Incidence Of Diseases Such As Cancer And Arthritis to Drive the Market GBIHC###MR /Published JUN #### Page # © GBI Research. This is a licensed product and is not to be...
Time and Cost Reduction in Clinical Trials- Outsourcing and IT to Optimize Patient Recruitment, Logistics, Data and Site ManagementJun 01, 2011
...Time and Cost Reduction in Clinical Trials- Outsourcing and IT to Optimize Patient Recruitment, Logistics, Data and Site Management GBIHC###MR / Published JUN #### Page # © GBI Research. This is a licensed product and is not to be photocopied Time and...
Lifesciences IT - 2011 YearbookJun 01, 2011
...Lifesciences IT - #### Yearbook GBIHC###MR/Published JUN #### Page # © GBI Research. This is a licensed product and is not to be photocopied Lifesciences IT - #### Yearbook Reference Code: GBIHC###MR Publication Date: June #### GBI Research expects that information technology...
Smartphone Integrated Circuits (IC) Market to 2020 - Greater Appetite for Connectivity ICs Including Wi-Fi, Bluetooth and GPS will Increase DemandMay 24, 2011
...Smartphone Integrated Circuits (IC) Market to #### - Greater Appetite for Connectivity ICs Including Wi-Fi, Bluetooth and GPS will Increase Demand GBISC####MR / Published MAY #### Page # © GBI Research. This is a licensed product and is not to be photocopied...
Technology Transfer Strategies - A Guide to Maximizing Returns Within the Pharmaceutical and Biopharmaceutical IndustriesMay 24, 2011
...Technology Transfer Strategies - A Guide to Maximizing Returns Within the Pharmaceutical and Biopharmaceutical Industries GBIHC###MR / Published MAY #### Page # © GBI Research. This is a licensed product and is not to be photocopied Technology Transfer Strategies - A Guide to Maximizing...
Innovations in Protein Kinase Therapies - Significant Proportion of Protein Kinase Pipeline Contains Small Molecule Drugs That Target OncologyMay 24, 2011
...Innovations in Protein Kinase Therapies - Significant Proportion of Protein Kinase Pipeline Contains Small Molecule Drugs That Target Oncology GBIHC###MR / Published MAY #### Page # © GBI Research. This is a licensed product and is not to be photocopied Innovations in Protein...
Risk Evaluation and Mitigation Strategy (REMS) - Opioids, Erythropoesis-Stimulating Agents and Cancer Therapeutics are the Most Important Classes That Require REMSMay 24, 2011
...Risk Evaluation and Mitigation Strategy (REMS) - Opioids, Erythropoesis-Stimulating Agents and Cancer Therapeutics are the Most Important Classes That Require REMS GBIHC###MR / Published MAY #### Page # © GBI Research. This is a licensed product and is not to be photocopied...